| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1257 | 2020 |
| SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ... Nature 587 (7833), 270-274, 2020 | 1209 | 2020 |
| Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation U Fiedler, Y Reiss, M Scharpfenecker, V Grunow, S Koidl, G Thurston, ... Nature medicine 12 (2), 235-239, 2006 | 1108 | 2006 |
| COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis RL Chua, S Lukassen, S Trump, BP Hennig, D Wendisch, F Pott, ... Nature biotechnology 38 (8), 970-979, 2020 | 995 | 2020 |
| Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection CB Messner, V Demichev, D Wendisch, L Michalick, M White, A Freiwald, ... Cell systems 11 (1), 11-24. e4, 2020 | 465 | 2020 |
| Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021 SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ... Jama 328 (16), 1604-1615, 2022 | 410 | 2022 |
| A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ... Cell 183 (4), 1058-1069. e19, 2020 | 325 | 2020 |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis D Wendisch, O Dietrich, T Mari, S von Stillfried, IL Ibarra, M Mittermaier, ... Cell 184 (26), 6243-6261. e27, 2021 | 311 | 2021 |
| The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia M Witzenrath, F Pache, D Lorenz, U Koppe, B Gutbier, C Tabeling, ... The Journal of Immunology 187 (1), 434-440, 2011 | 303 | 2011 |
| IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid J Naujoks, C Tabeling, BD Dill, C Hoffmann, AS Brown, M Kunze, ... PLoS pathogens 12 (2), e1005408, 2016 | 242 | 2016 |
| Adrenomedullin reduces endothelial hyperpermeability S Hippenstiel, M Witzenrath, B Schmeck, A Hocke, M Krisp, M Krüll, ... Circulation research 91 (7), 618-625, 2002 | 241 | 2002 |
| Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1β, depending on listeriolysin O and NLRP3 K Meixenberger, F Pache, J Eitel, B Schmeck, S Hippenstiel, H Slevogt, ... The Journal of Immunology 184 (2), 922-930, 2010 | 236 | 2010 |
| Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis MO Becker, A Kill, M Kutsche, J Guenther, A Rose, C Tabeling, ... American journal of respiratory and critical care medicine 190 (7), 808-817, 2014 | 217 | 2014 |
| Coronaviruses as the cause of respiratory infections VM Corman, J Lienau, M Witzenrath Der Internist 60, 1136-1145, 2019 | 196 | 2019 |
| Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia M Witzenrath, B Schmeck, JM Doehn, T Tschernig, J Zahlten, JM Loeffler, ... Critical care medicine 37 (2), 642-649, 2009 | 189 | 2009 |
| Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis A Kill, C Tabeling, R Undeutsch, AA Kühl, J Günther, M Radic, MO Becker, ... Arthritis research & therapy 16, 1-12, 2014 | 184 | 2014 |
| Presence of SARS-CoV-2-reactive T cells in COVID-19 patients and healthy donors J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ... MedRxiv, 2020 | 182 | 2020 |
| Tumor necrosis factor-α–dependent expression of phosphodiesterase 2: Role in endothelial hyperpermeability J Seybold, D Thomas, M Witzenrath, S Boral, AC Hocke, A Bürger, ... Blood 105 (9), 3569-3576, 2005 | 180 | 2005 |
| Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised … APJ Vlaar, S de Bruin, M Busch, SA Timmermans, IE van Zeggeren, ... The Lancet Rheumatology 2 (12), e764-e773, 2020 | 177 | 2020 |
| Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19 S Trump, S Lukassen, MS Anker, RL Chua, J Liebig, L Thürmann, ... Nature biotechnology 39 (6), 705-716, 2021 | 160 | 2021 |
